Fair-Eye Net: A Fair, Trustworthy, Multimodal Integrated Glaucoma Full Chain AI System
1 st Wenbin Wei, 1 st Suyuan Yao, 1 st Cheng Huang, 1 st Xiangyu Gao · 2026
Read Fair-Eye Net: A Fair, Trustworthy, Multimodal Integrated Glaucoma Full Chain AI System by 1 st Wenbin Wei, 1 st Suyuan Yao, 1 st Cheng Huang, 1 st Xiangyu Gao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2601-18464.txt.
Introduction
Wenbin Wei, Suyuan Yao, Cheng Huang, and Xiangyu Gao build a full chain AI tool for glaucoma, a disease that steals sight bit by bit. The disease is a top cause of sight loss that cannot be undone. Early finds and steady checks can save sight, but care now leans on one test at a time. Those tests leave room for whim and for gaps in care.
Their tool joins many kinds of test in one flow, from first screen to long term watch. It aims to give the same grade of care in each place, not just where top kit and top staff sit. A fair chain could help more people keep their sight. It could also cut the load on eye clinics that now face long lines. The team frame the tool as one that users can trust, with clear steps from test to choice.
Catalog record
| CREATOR | 1 st Wenbin Wei, 1 st Suyuan Yao, 1 st Cheng Huang, 1 st Xiangyu Gao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2601-18464
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Fair-Eye Net: A Fair, Trustworthy, Multimodal Integrated Glaucoma Full Chain AI System 1 st Wenbin Wei, 1 st Suyuan Yao, 1 st Cheng Huang, 1 st Xiangyu Gao Abstract Glaucoma is a top cause of irreversible blindness globally, making early detection and longitudinal follow-up pivotal to preventing permanent vision loss. Current screening and progression assessment, however, rely on single tests or loosely linked examinations, introducing subjectivity and fragmented care. Limited access to high-quality imaging tools and specialist expertise further compromises consistency and equity in real-world use. To address these gaps, we developed Fair-Eye Net, a fair, reliable multimodal AI system closing the clinical loop from glaucoma screening to follow-up and risk alerting. It integrates fundus photos, OCT structural metrics, VF functional indices and demographic factors via a dual-stream heterogeneous fusion architecture, with an uncertainty-aware hierarchical gating strategy for selective prediction and safe referral. A fairness constraint reduces missed diagnoses in disadvantaged subgroups. Experimental results show, it achieved an AUC of 0.912 (96.7% specificity), cutting racial false-negative disparity by 73.4% (12.31% to 3.28%), maintained stable cross-domain performance, and enabled 3–12 months of early risk alerts (92% sensitivity, 88% specificity). Unlike post hoc fairness adjustments, Fair-Eye Net optimizes fairness as a primary goal with clinical reliability via multitask learning, offering a reproducible path for clinical translation and large-scale deployment to advance global eye health equity. I Introduction Glaucoma is a major cause of irreversible blindness. Because early disease is often asymptomatic, diagnosis is commonly delayed until permanent optic-nerve injury has occurred [ 1 ] . Global burden is substantial: 85 million cases were estimated in 2025, with projections of roughly 112 million by 2040 [ 2 ] . Late detection increases lifetime blindness risk and health-care costs; scalable early detection and risk forecasting are therefore central to prevention strategies [ 3 ] . However, current screening and follow-up typically combine fundus photography, optical coherence tomography (OCT), and visual-field testing, but these assessments are often interpreted in isolation. Subjective grading, fragmented longitudinal records, and uneven access to equipment and expertise limit consistent population screening and ongoing risk management. Multimodal AI systems that are interpretable, uncertainty-aware, and fair are needed to support clinical decisions under real-world resource constraints. The 2030 In Sight initiative explicitly calls for tools that are adaptable to resource differences, interpretable, and sustainable [ 4 ] . In recent years, deep learning has improved glaucoma detection from fundus photographs [ 5 ] , and integrating structural indicators such as retinal nerve fiber layer thickness (RNFLT) from OCT with functional measures such as visual-field mean deviation (MD) and its longitudinal change can further boost performance [ 6 ] . Translating multimodal advances into a sustainable and equitable clinical workflow remains difficult for four reasons. First, although generalist medical foundation models are emerging [ 7 ] and glaucoma-specific multimodal datasets and methods are growing [ 8 , 9 ] , explicit cross-modal alignment and mutual verification are still limited, and transfer across modalities and sites remains immature. Second, uncertainty quantification is rarely operationalized: most systems output a single deterministic probability, while Monte Carlo dropout and test-time augmentation are not consistently tied to dual outputs (risk and confidence) or to an actionable decision workflow [ 10 , 11 ] . Third, cross-domain generalization is fragile; device and protocol differences across centers induce distribution shifts, and forcing predictions on out-of-distribution samples can create safety risks, making uncertainty-aware rejection essential [ 12 , 13 ] . Fourth, fairness risks persist: subgroup performance differences and calibration errors can propagate bias, yet joint optimization of fairness constraints and credible rejection remains underexplored [ 14 , 15 , 13 ] . To address these barriers, we propose Fair-Eye Net, a multimodal fundus-based system for early glaucoma screening, progression prediction, and dynamic risk warning. The design targets four objectives: accuracy through heterogeneous fusion, trustworthy decisions via interpretability and uncertainty, robustness under domain shift, and fairness as a first-class constraint. These components form a closed-loop workflow spanning automated screening, uncertainty-aware triage, clinician review, and iterative model improvement. 1) Multimodal heterogeneous fusion with representation transfer: We use a dual-stream framework that couples fundus-image representations pretrained at scale with clinical phenotypes, integrating structural (RNFLT/OCT), functional (MD and progression), and risk-factor variables to unify screening and progression-slope estimation [ 16 ] . 2) Uncertainty-driven dynamic gating and selective prediction: We quantify predictive uncertainty to output paired measures of risk and confidence, and use them to drive selective prediction, targeted review, and iterative refinement for safer use [ 17 ] . 3) Cross-domain robustness: To handle multi-center and cross-device shifts, we combine representation adaptation with uncertainty-based filtering to improve external validity and deployment stability [ 18 ] . 4) Fairness-aware constraints and prioritization: We impose fairness constraints during model development and prioritize review for potentially disadvantaged subgroups to limit bias amplification and improve service consistency [ 19 ] . Fair-Eye Net links screening, prediction, and risk warning within one pipeline. The uncertainty gate is designed to improve throughput without compromising clinical safety, consistent with an assist-not-replace role for AI. By integrating robustness and fairness into model design and evaluation, the system targets sustainable multi-center deployment aligned with global eye-health goals [ 4 ] . The remainder of this paper is organized as follows: Section 2 reviews related work; Section 3 presents the Fair-Eye Net architecture and learning strategy; Section 4 describes datasets and evaluation; Section 5 reports results with ablations and discussion; and Section 6 concludes. II Related Work Glaucoma AI has progressed from single-modality, cross-sectional screening to multimodal fusion and longitudinal risk modeling. Retinal foundation models such as RETFound learn transferable representations via large-scale pretraining, reducing label dependence and improving cross-task, cross-center, and cross-device generalization [ 16 ] . Building on these representations, recent work has shown that low-cost color fundus photographs can support not only detection but also prediction of glaucoma incidence and progression, enabling earlier risk stratification where advanced testing is limited [ 20 ] . Clinical decision-oriented studies increasingly integrate heterogeneous information and emphasize interpretability. Transformer-based models can leverage ophthalmology free-text notes to forecast progression to surgical treatment, highlighting the prognostic value of unstructured narratives [ 21 ] . Combining structured electronic health record (EHR) variables with RNFL-OCT measurements improves near-term progression prediction and supports feature-level explanations via attention mechanisms or SHAP [ 22 ] . Multimodal pipelines that take both color images and OCT as input further demonstrate modality complementarity, but also expose practical constraints such as limited paired data, device heterogeneity, and sensitivity to task definitions [ 23 ] . For real-world deployment, the focus has shifted from maximizing AUC on curated benchmarks to maintaining stable, reliable, and fair performance under distribution shift. Uncertainty quantification and selective prediction can reduce confident errors on out-of-distribution samples, and evidence-based formulations support calibrated rejection strategies [ 13 ] . Domain adaptation has been explored to mitigate training-target gaps and improve cross-domain diagnostic and prognostic performance [ 24 ] . Regarding fairness, fair identity normalization and subgroup-aware metrics (e.g., ES-AUC) can reduce performance disparities for under-represented groups, suggesting that fairness should be embedded in both training and evaluation [ 15 ] . Multi-center EHR risk models further show that generalization can vary across internal and external tests, emphasizing validation matched to the intended